Reval has released version 4.2 of HedgeRxTM. Its features include derivative instruments, an expanded range of independent valuations and the IAS 39 Doctor, a documentation tool for compliance with derivative reporting requirements under international financial reporting standards (IFRS). HedgeRx offers new coverage and independent valuations of instruments ranging from Mexican TIEE to Singapore dollar interest rate swaps. “We’re already live with IAS 39 with European clients and continue to add features at the advice of the big four accounting firms and their clients” says Philip Pettinato, COO of Reval. “Our IAS 39 Doctor is another example of how we make it easier to understand and comply with new regulatory requirements.” The IAS 39 Doctor allows companies to understand the accounting effect of hedging strategies and provides the at-inception documentation required under the standard.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more